Lyophilised · batch-documented · discreet packaging
FOXO4
D-Retro-Inverso Senolytic Peptide // FOXO4-p53 Disruptor // Longevity Research
Targeted elimination of senescent cells. The first peptide-based senolytic with published reversal of ageing phenotypes.
FOXO4-DRI is a D-amino acid retro-inverso peptide designed to disrupt the FOXO4-p53 protein-protein interaction in senescent cells. Senescent cells accumulate with ageing and drive chronic inflammation (inflammaging) via the senescence-associated secretory phenotype (SASP). By blocking FOXO4 from sequestering p53 in the nucleus, the peptide restores p53's apoptotic function specifically in senescent cells, triggering their elimination without harming healthy cells. Published research in Nature Medicine (Baar et al., 2017) demonstrated reversal of ageing phenotypes and increased physical fitness in mice.
Third-party tested
Every batch independently verified by Janoshik & Freedom Diagnostics for purity and identity.
Full COA included
Certificate of Analysis confirms peptide purity, amino acid composition, and absence of contaminants.
Discreet shipping
Every order ships in plain, unmarked packaging with full tracking. No external branding or product details visible.
Research-grade
Uniform vial presentation, consistent labeling, and batch-level documentation every time.
- Janoshik & Freedom Diagnostics verified
- Certificate of analysis per batch
- Direct-from-manufacturer sourcing
- Discreet, unmarked packaging